Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Return on Assets [ROA] (2018 - 2026)

Updated

Vitaspring Biomedical's Return on Assets [ROA] came in at -3471.04% for fiscal Q2 2027 (quarter ended Jul 31, 2026), up 198.36 percentage points from -3669.40% a year earlier but down 325.10 percentage points from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2026 (ended Jan 31, 2026), Vitaspring Biomedical's Return on Assets [ROA] was -2859.28%, down 1837.77 percentage points from FY2025.

  • Return on Assets [ROA] has declined in each of the last four fiscal years, with a five-year change of -2410.09 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Assets [ROA] was -1021.52% in FY2025 (-773.85 pp), -247.66% in FY2024 (-244.11 pp), -3.55% in FY2023 (-51.50 pp) and 47.95% in FY2022 (+497.15 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -4858.36% (fiscal Q1 2026) to 56.68% (fiscal Q4 2022).
  • Year-over-year, Return on Assets [ROA] increased in three of the last eight quarters, with an average year-over-year change of -1053.77 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q1 2027 (a gain of 1712.42 percentage points), and the weakest in fiscal Q1 2026 (a drop of 4090.92 percentage points).
  • Business Quant data shows VSBC's Return on Assets [ROA] at -3145.94% (Q1 2027), -2667.66% (Q4 2026) and -2849.28% (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn - -3,471.04%
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -3,471.04%
Apr 30, 2026 -3,145.94%
Jan 31, 2026 -2,667.66%
Oct 31, 2025 -2,849.28%
Jul 31, 2025 -3,669.40%
Apr 30, 2025 -4,858.36%
Jan 31, 2025 -2,130.08%
Oct 31, 2024 -1,397.02%
Jul 31, 2024 -915.92%
Apr 30, 2024 -767.44%
Jan 31, 2024 -539.47%
Oct 31, 2023 -1,480.91%
Jul 31, 2023 -1,039.35%
Apr 30, 2023 -722.01%
Jan 31, 2023 -259.52%
Oct 31, 2022 48.80%
Jul 31, 2022 46.47%
Apr 30, 2022 51.49%
Jan 31, 2022 56.68%
Oct 31, 2021 -25.20%
API Access

Vitaspring Biomedical Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VSBC&period=max&api_key=YOUR_API_KEY